In a mouse model of lung cancer, elevated expression of TIM-3 was similarly observed on anti-PD-1 antibody-bound T cells, and subsequent blockade of TIM-3 improved overall survival than PD-1 blockade alone. This evidence concerns the gene HAVCR2 and lung cancer.